NEW YORK, April 28, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for AngioDynamics, Inc. shareholders (NASDAQ:ANGO). Concerned ANGO investors who purchased between October 9, 2014 and April 9, 2015 are encouraged to contact securities attorney Hamilton Lindley by clicking here.
AngioDynamics, Inc. reported, on April 9, 2015, a quarterly loss of $4.3 million and revised its net sales outlook for the 2015 fiscal year to a range of $356 million to $360 million from its prior outlook of a range of $362 million to $368 million. The price of the stock declined dramatically on this news.
Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. ANGO stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at [email protected] with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/ANGO.
SOURCE Dunnam & Dunnam